Free Trial

Steven Seedhouse Analyst Performance

Analyst at Raymond James Financial

Steven Seedhouse is a stock analyst at Raymond James Financial focused in the medical sector, covering 22 publicly traded companies. Over the past year, Steven Seedhouse has issued 14 stock ratings, including strong buy and buy recommendations. While full access to Steven Seedhouse's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Steven Seedhouse's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
72 Last 6 Years
Buy Recommendations
84.72% 61 Buy Ratings
Companies Covered
22 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy20.8%15 ratings
Buy63.9%46 ratings
Hold12.5%9 ratings
Sell2.8%2 ratings

Out of 72 total stock ratings issued by Steven Seedhouse at Raymond James Financial, the majority (63.9%) have been Buy recommendations, followed by 20.8% Strong Buy, 12.5% Hold, and 2.8% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
22 companies

Steven Seedhouse, an analyst at Raymond James Financial, currently covers 22 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
21 companies
95.5%
Computer and Technology
1 company
4.5%

Steven Seedhouse of Raymond James Financial specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
11 companies
50.0%
PHARMACEUTICAL PREPARATIONS
5 companies
22.7%
MED - DRUGS
2 companies
9.1%
BIOTECHNOLOGY
2 companies
9.1%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
4.5%
PREPACKAGED SOFTWARE
1 company
4.5%

Steven Seedhouse's Ratings History at Raymond James Financial

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
9/17/2025Reiterated Rating$7.64$49.00Overweight
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
9/9/2025Reiterated Rating$33.61$63.00Outperform
Korro Bio, Inc. stock logo
KRRO
Korro Bio
8/13/2025Lower Price Target$15.99$147.00Strong-Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/7/2025Reiterated Rating$59.48Strong-Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/7/2025Boost Price Target$53.39$82.00Strong-Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
5/13/2025Boost Price Target$45.12$77.00Strong-Buy
InflaRx N.V. stock logo
IFRX
InflaRx
4/29/2025Initiated Coverage$1.22$10.00Overweight
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
4/29/2025Initiated Coverage$8.32$20.00Overweight
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
4/29/2025Initiated Coverage$6.83$10.00Overweight
Pharvaris N.V. stock logo
PHVS
Pharvaris
4/29/2025Initiated Coverage$17.06$28.00Overweight
Korro Bio, Inc. stock logo
KRRO
Korro Bio
4/28/2025Initiated Coverage$17.47$74.00Overweight
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
4/28/2025Initiated Coverage$4.96$47.00Overweight
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
4/28/2025Initiated Coverage$25.94$104.00Overweight
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
2/6/2025Boost Price Target$31.28$125.00Strong-Buy